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Plastic-adherent cells enriched for dendritic cells 
(AC) were  found to be  among the most potent stim- 
ulator cells for the activation of cytotoxic T lympho- 
cytes (CTL) in oitro in  the presence of interleukin 2 
(IL 2) and a constant second set of allogeneic stim- 
ulator cells. Concanavalin  A-activated  nylon wool- 
nonadherent spleen cells (CNWT), concanavalin A- 
activated unfractionated spleen cells (Cspl), and 
some variants of the ESb T lymphoma line were 
equally  effective as stimulator cells, however, and 
provoked a substantial cytotoxic response at con- 
centrations of IO4 cells per culture or less. In con- 
trast, nonactivated nylon  wool-nonadherent spleen 
cells (NWT) or unfractionated spleen cells (Spl) and 
cells of the P815 mastocytoma, the Meth A fibrosar- 
coma, and the T cell lymphomas Ly 5178 Eb and 
ESb did not stimulate cytotoxic responses at these 
cell concentrations. The strong stimulatory poten- 
tial of the Cspl preparation was  reduced by treat- 
ment with anti-Thy-1 antibody plus complement, 
whereas the stimulatory activity of the AC prepa- 
ration was resistant  to  this treatment. All cell types 
tested expressed class I major histocompatibility 
antigens. Nonactivated NWT cells, in contrast  to  the 
CNWT preparation, showed  no detectable staining 
with  anti-I-E or anti-I-A antibodies and also a 
slightly weaker staining with class I antisera. Ex- 
periments with the tumor cell lines revealed, how- 
ever, that  there was  no strict correlation between 
stimulatory potential and density of class I alloan- 
tigens or the expression of I-E determinants. Exper- 
iments on primary cytotoxic responses in vivo gave 
similar results. Experiments  in cultures with a sin- 
gle set of stimulator cells and I region-compatible 
responder cells indicated that AC and Cspl or CNWT 
also have a markedly stronger capacity than NWT 
to induce IL 2-dependent DNA synthesis. 
It has been reported that proliferative or cytotoxic re- 
sponses in mixed lymphocyte reactions require non-T, 
non-B Ia' accessory cells as stimulator cells. Dendritic 
cells (1-6) and macrophage-like cells (7, 8) have been 
identified as the most effective stimulator cells for these 
reactions. More detailed studies  indicated, however. that 
the Ia' accessory cells are required as stimulator cells for 
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the  interleukin 2 (IL 2)-producing helper T cells (5, 9); it 
was suggested that  in  the presence of sufficient  helper 
factor (IL 2) cytotoxic T lymphocyte (CTL)' precursor cells 
do not  require  a  special type of stimulator cells (91, and 
that they may be activated even by metabolically inacti- 
vated cells (1  0- 13) or by noncellular  antigen (14- 19). 
Unfortunately, these studies contained no quantitative 
comparison of graded numbers of stimulator cells. The 
work of Austyn et al. (20)  indicated.  on the  other  hand, 
that dendritic cells are  the principal  stimulator cells for 
IL 2 production as well as for the induction of IL 2 
responsiveness. 
To resolve this  apparent discrepancy, we studied the 
capacity of a  number of different cell types to activate 
CTL in  the  presence of IL 2. Our experiments revealed 
that plastic-adherent cells (AC) (enriched for dendritic 
cells) are indeed on a per cell basis 10- to 30-fold more 
effective than nylon wool-nonadherent  spleen cells 
[NWT) and  are more effective than unfractionated  spleen 
cells (Spl) or  several  lines of tumor cells, including P815 
mastocytoma cells, Meth A fibrosarcoma  cells, and some 
lymphoma lines.  Concanavalin A-activated T cells and 
some T cell lymphoma lines, on the other hand, were 
found  to  stimulate as effectively as the AC preparation. 
The  experiments indicated that  the presence of antigen 
on the  surface of stimulator cells (in this  case allogeneic 
H-2  determinants) is not sufficient for efficient stimula- 
tion of the CTL precursor cells. Some types of stimulator 
cells obviously provide an  additional  activating  signal, 
possibly a soluble mediator that mediates relatively effi- 
cient  stimulation of the CTL precursor cells or the  stim- 
ulation of a yet unknown antigenically linked helper 
effect that is required for the cytotoxic response id addi- 
tion  to  antigen and IL 2. 
It is quite conceivable that  the stimulator cells produce 
[or stimulate  the production of) one of the helper  factors 
that  are required in addition to IL 2 for the activation of 
CTL (21-28). However, the reports on these additional 
factors  (21-28)  have not dealt with antigen-specific as- 
pects of these helper  effects, i.e., they did not indicate 
whether  the  factors  are d livered by a cognate interaction 
that involves the  antigen receptor of the CTL precursor 
cell. The  experiments in this report  demonstrate  the an- 
tigen-specific aspect of the additional  activating  signal. 
Previous studies provided essentially two explanations 
' Abbreviations used: AC. plastic-adherent  spleen cells: CTL, cytotoxic 
T lymphocyte(s): CNWT. NWT cultured in the presence of Con A; Cspl. 
wool-nonadherent  spleen cells; PMA. phorbol myristic acetate: Spl. un- 
spleen cells cultured in  the presence of Con A; NWT. T cell-enriched nylon 
fractionated  spleen cells; FACS. fluorescence-activated cell sorter. 
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for the  usual  failure of tumor cells to  stimulate cytotoxic 
responses in  vivo. First,  the cytotoxic responses may be 
inhibited by suppressor cells (29-33). and secondly, tu- 
mor cells may be inadequate  stimulator cells for the IL 2- 
producing helper  T cells (1 2). The  experiments  in  this 
report  indicate that tumor cells may be weak  stimulator 
cells for cytotoxic responses  even  in  the  absence of de- 
tectable  suppression and in  the presence of IL 2-contain- 
ing cell supernatants  and/or  an  unrelated  set of alloge- 
neic stimulator cells. 
MATERIALS AND METHODS 
Animals. Mice of the  strain C3H.  DBA/2, BALB/c. and C57BL/6 
were purchased from Bomholtgard, Ry. Denmark. The C3H.OH. 
A.TL, and A.SW mice  were maintained at   the German  Cancer Re- 
search  Center  and were originally derived  from the  Jackson Labo- 
ratory, Bar Harbor, ME. 
35) was kindly provided by Dr.  G. Hammerling. Heidelberg. Eb  737 
Tumor  lines. The  P815 mastocytoma line, of DBA/2 origin (34. 
is a cloned subline of the  methylcholanthrene-induced DBA/2 T cell 
lymphoma Ly 5178 YEb (36): ESb  721 is a cloned subline of the  ESb 
T cell lymphoma,  which developed spontaneously as a metastasizing 
variant from the weakly metastasizing  Eb  tumor (36.37). The  tumor 
line ESbM was isolated by M. Fogel and V. Schirrmacher as a plastic- 
adherent  spontaneous  variant of the  ESb  tumor line, and showed 
only weak metastasizing potential (38). The ESbD line  was prepared 
the ESb line by Drs. J .  W. Dennis, R. S .  Kerbel. and V. Schirrmacher. 
by mutagenization as a ouabain  and  thioguanin-resistant  variant of 
Meth A fibrosarcoma line (BALB/c) (39)  and  the  Rauscher leukemia 
All these  tumor  lines together with  the  methylcholanthrene-induced 
virus-induced T cell lymphoma line RBL/5 (C57BL/6) (40) were 
kindly provided by Dr. V. Schirrmacher. Heidelberg. ESbW was 
another  ouabain  and  thioguanin-resistant  variant of the ESb  line 
and  was  also produced by mutagenization by A. Wehrmaker.  The 
corresponding H-2 genotype of these  tumors  was confirmed  with a 
panel of alloreactive CTL preparations  (data  not  shown)  and  with 
monoclonal anti-H-2  antibodies  (Tables VI11 and 1X). 
Activation of cytotoxic responses in vitro. Twenty million re- 
volume of 4.5 ml culture medium (RPMl 1640. GIBCO medium sup- 
sponder cells (usually C3H spleen cells) were incubated  in a total 
plemented  with 10 mM L-glutamine (GIBCO. Grand  Island, NY) strep- 
tomycin/penicillin (GIBCO: 100 U/ml), 0.5% HEPES (GIBCO). 10% 
fetal calf serum (GIBCO). and 3 x M 2-mercaptoethanol together 
with  0.4 ml of a n  IL 2 (about 100 U/ml)-containing EL-4 supernatant 
and  various  combinations of irradiated ( 1  500 rad) or mitomycin C- 
treated allogeneic stimulator cells for 5 days  at 37°C in 5% COa if 
not indicated  otherwise. The  cultures  usually received a variable set 
of stimulator cells (irradiated  tumor cells or spleen cells a t  graded 
doses) plus a constant set of 5 x lo5 irradiated allogeneic spleen 
cells from a n  unrelated H-2 haplotype. Responder and  stimulator 
cells  were Spl if not indicated  otherwise.  Unless  indicated, the cul- 
tures were  tested after 5 days for cytotoxic activity against  concan- 
avalin A-activated spleen cell blasts  in a 4-hr "Cr-release assay as 
described (21,  41). 
Activation  ofcytotoxic  responses  in vivo. Mice (usually 8- to 12- 
wk-old male C3H mice] were treated with 3 mg cyclophosphamide 
(Endoxan,  Asta, Brackwede, Germany)  in  0.15 ml saline i.p. 2 days 
before immunization if not indicated  otherwise. The immunization 
was performed by distributing  the indicated allogeneic cell prepara- 
tions equally into  the  four  footpads in a total volume of 0.2 ml. Five 
days  after  immunization,  the mice were  sacrificed, and  the pooled 
inguinal  and  axillary l mph  nodes  were  directly  tested in a 4-hr 5'Cr- 
release assay for cytotoxic activity on concanavalin A-activated 
lymphoblasts as target cells if not  indicated  otherwise. The  attacker 
to  target cell ratios were 100: 1 ,  30: 1, 1 1 : 1 ,  3.6.1,  and 1.2: 1. 
ated with a dose of 1500 rad (unless indicated  otherwise) either with 
Irradiation of stimulator cells. The  stimulator cells  were  irradi- 
a Gammatron (Siemens, Erlangen. Germany) designed for human 
therapy  and equipped  with  a 6oCo source or with a Gammacell 1000 
D (Atomic Ener of Canada Limited, Commercial  Products]  equipped 
with a 2300 Ciq7Cs source  (1700  rad/min). 
lator cells (max. lo7 cells/ml) were incubated  with 0.04 mg/ml of 
Treatment of stimulator  cells  with  rnltomycin C. Splenic  stimu- 
mitomycin C (Sigma Chemical Co.. St. Louis, MO) for 45  min  and 
were then  washed  three  times. Tumor  cells  were treated  with 0.08 
mg/ml mitomycin C. 
The preparation of ZL 2-containing supernatants from EL-4 
thymoma  cells. Supernatants were  obtained from a n  IL-2-producing 
EL-4 subline (kindly provided by Dr. J. Farrar)  after induction  with 
phorbol  myristic acetate (PMA) as described (42). Briefly, IOe EL-4 
cells/ml were incubated together  with 10 ng/ml PMA (Sigma) for 48 
hr.  The  supernatant  was collected and stored  frozen at  -20°C. 
Preparation of T cell-enriched  nylon  wool-nonadherent  spleen 
cells. Lymphoid cells were incubated in nylon wool columns and 
eluted as described (43). 
The  preparation of "plastic-adherent  cells" (A&). The  term 'plas- 
tic-adherent  spleen cells" was used in  this report  for a fraction of 
spleen cells  prepared by a procedure that  has been reported to  enrich 
especially for dendritic  cells (6). Spleen  cells  from three mice (about 
3 X 10' cells) were incubated in 10 ml culture medium in plastic 
petri dishes with a 10-cm diameter (Greiner, Niirtingen. W. Ger- 
many, type TC94/16) a t  37°C. After 2 hr. the supernatant was 
discarded, the  nonadherent cells  were  washed off carefully by exten- 
sive rinsing  with  warm  culture medium or ESS. and  the AC were 
again  incubated  with 10 ml of fresh  culture medium for another  18 
hr.  The cells that  detached  spontaneously  during  this  time period 
(usually 1 to 2 X 10' cells)  were then collected in the  supernatant 
and used as the  "plastic-adherent  spleen cell population" in these 
studies. According to  reports from another laboratory (6). this pop- 
ulation I s  a mixture of dendritic cells (80 to  95%)  and macrophages. 
Prefncubatlon  ofstimulator  cells. In some  experiments,  the  stim- 
ulator cells  were cultured at  a density of 1.5  to 2 X IO7 cells per 4.5 
ml culture medium for 30  min  or  24  hr with variable amounts (0 to 
0.08 mg) of concanavalin A (Con A) (Pharmacia) or 45 ng PMA per 
culture. 
of monoclonal antibodies (see  Tables VI11 and IX) were  kindl pro- 
Fluorescence  staining and  cytofluorographtc  analysts. A series 
vided by Dr. G. Hammerling, DKFZ, Heidelberg. First, 5 X 10 Y cells 
in  0.05 ml were mixed with 0.05 ml of appropriately  diluted  antibody 
and  then  incubated  for 30 min at  4°C. The cells  were then mixed 
with 0.1 ml Dulbecco's phosphate saline (PBS: Seromed). centri- 
fuged, and  washed twice with 0.2 mi  PES. The  resultingcell  sediment 
was  then  resuspended In 0.05 ml fluorescein  isothiocyanate-labeled 
goat anti-mouse immunoglobulin  (Sigma  F 7506: diluted 1/30)  and 
incubated  again  for 30 min at  4OC. The cells  were  finally washed 
twice with PES as described before. 
Ortho  Instruments, Westwood. MA). Scatter  gates were set to exclude 
The  stained cells  were  analyzed  on a cell sorter (NHP Spectrum 3, 
non-viable  cells. The positive cells  were  defined as having a fluores- 
yield a maximum of positive cells with  the relevant antibodies  and 
cence intensity above a n  arbitrary  threshold. which was  chosen  to 
at the  same  time a minimum (usually less  than  12%) of positive cells 
with an irrelevant control  antibody. 
RESULTS 
Dwerent  subpopulations of spleen  cells  dfler  mark- 
edly  in  their  capacity  to  stimulate  cytotoxic  responses 
even  in  the  presence of IL 2 and a second  unrelated  set 
of stimulator  cells. Cytotoxic responses were studied in 
4.5-ml  cultures  with 2 X lo7 responder cells and  0.4 ml 
of an IL 2-containing EL-4 supernatant plus graded num- 
bers of different allogeneic spleen cell subpopulations as 
stimulator cells. In addition, the  cultures routinely con- 
tained  a second and  constant  set of unrelated  stimulator 
cells to provide an additional source for antigenically 
unlinked  helper activity. The response  against this  sec- 
ond set of stimulator cells provided a convenient control 
for the availability of unlinked  helper activity (Le., IL 2) 
in the  culture  and  has therefore  also been included in the 
figures and tables. With this  system, we found strong 
differences  in the stimulatory  potential of different 
spleen cell fractions. The T cell-enriched nylon wool- 
nonadherent fraction of spleen cells (NWT) stimulated 
substantial cytotoxic responses only in numbers of 2 X 
lo5 cells or more, and practically no  responses occurred 
when applied in numbers of 5 X lo4 or  less (Figs. 1-4). 
In contrast, a  preparation of AC with a high proportion 
of dendritic cells (see Materials  and  Methods) timulated 
substantial cytotoxic responses  already at a  concentra- 
tion of IO4 cells per  culture (Figs. 1 and 2).  The  titration 
of these two types of stimulator cells revealed an  at  least 
IO-fold difference in the stimulatory potential (Fig. 1). 
The Spl preparations were usually slightly more effective 
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number of variable  stimulator cells 
Figure 1. Titration of different stirnulator cell preparations in the presence of IL 2 and a second set of allogeneic  stimulator cells.-C3H responder 
cells (H-2*) (2 x 10') were  incubated in 4.5-1111 cultures with 0.4 ml EL-4 supernatant plus 5 X loJ A S W  stimulator cells (H-2') and a variable  number 
of C57BL/6  stimulator cells [H-zb) (left panel) or DBA/P stimulator cells [H-Zd) (rfght panel). The  stimulator cells had  been  irradiated  with a dose ,of 
WJ. Open symbols, the cytotoxic responses against the variable stimulator cells. They  were  determined  with  BL/6  targets [lejt  panel) or BALB/c 
1500 rad from the Gammatron. The ASW  cells were always Spl. The variable stimulator cells were either Spl [w], NWT (A-A). or AC 
targets [H-2d) [rfght panel). Solid symbols, corresponding  cytotoxic activities on A.SW targets. Data show "Cr release at attacker to target cell ratios 
of 5: 1 [top  panel) and 25:l [bottom  panel). Figure illustrates the dose-dependent  cytotoxic response agalnst the variable sets of stimulator cells and 
the practically constant response [solfd symbols) against the constant set of stimulators. 
than the NWT fractions (Fig. 1). The experiments re- 
vealed also that  the type and concentration of the vari- 
able  stimulator cell had  practically  no  influence  on the 
response against  the second (constant)  set of stimulator 
cells (Fig. 1). 
The weak stimulatory potential of the NWT fraction 
is not the result of a suppressive activity. The possibil- 
ity that  the weak stimulatory  potential of the NWT might 
have  resulted  from  active  suppression was tested  in ex- 
periments in which NWT were mixed with the strongly 
stimulatory preparation of  AC [Fig. 2, Table I). These 
experiments revealed a slight degree of suppression at  
times,  which  was  nevertheless  not  sufficient  to  explain 
the complete lack of stimulatory activity of the NWT 
numbers of 5 x lo4 or  less (Fig. 1). 
The NWT fraction can express strong  stirnulatory 
activity after incubation with Con A. When NWT were 
incubated at  cell densities of 1.5 to 2 X lo7 cells in 4.5 
ml together  with 0.01 mg Con A per  culture for 24  hr, 
they  expressed strong  stimulatory  activity (Fig. 3). This 
activity  was  about as  good as the  stimulatory potential of 
the AC population  (see Fig. 1).  The results from Figures 
1 and 3 were obtained in a single experiment and  are 
therefore directly comparable.  The  experiment  in Figure 
3 shows also that the incubation of the NWT in the 
absence of Con A or  in  the presence of 10 ng/ml of PMA 
was not sufficient  to  enhance  the  stimulatory potential. 
Additional experiments showed that a 30-min  incuba- 
tion of NWT with Con A (CNWT) was not  sufficient  to 
induce the  stimulatory potential (Fig. 4). This  result  sug- 
gested that  the expression of stimulatory potential re- 
sulted from true activation of the  stimulator cells. Incu- 
bation of Spl  with Con A also enhanced  the stimulatory 
activity of this population [data not shown). 
Thymic responder cells in comparison with splenic 
responder cells showed even greater  differences  in  their 
cytotoxic responses  against Con A-activated (CNWT) us 
nonactivated NWT stimulator cells [data  not  shown).  This 
result suggested that  the splenic  responder cells contain, 
in contrast to the thymic  responder  cells,  a  small  subset 
of  CTL precursor cells (possibly the Lyt- 1-2+ population), 
which  does  not  require the additional  activating  signal 
from the Con A-activated stimulator cell. 
Failure  to demonstrate a synergistic eflect between 
dmerent stimulator cell preparations. The  experiments 
described above had  shown that a relatively strong  stim- 
ulatory activity was provided  by two apparently  different 
stimulator cell preparations,  namely CNWT and  the AC 
fraction of spleen cells (Figs. 1 and 3). This finding raised 
the question  whether the optimal activation of CTL re- 
quires  the combined action of two functionally  different 
types of stimulator  cells, namely activated  T cell blasts 
and dendritic cells or macrophages. The two stimulator 
cell preparations might have contained predominantly 
one of these two cell types plus contamination of the 
other type of cell. One would have expected in  this  case 
a  strong  synergistic effect of  CNWT stimulator cells and 
AC stimulator cell preparations.  Such  a  synergistic effect 
was  not observed (Table 11). 
Anti-Thy-1 serum plus complement IC) reduced the 
stimulatory activity of Con A-activated spleen cells 
(Cspl)  but not that of the AC preparation. Another  inter- 
pretation of the  strong stimulatory activity of the two 
different  stimulator cell preparations  was that  the AC 
preparation contained a substantial number of T cell 
blasts.  Experiments  showed, however, that  the  stimula- 
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E) 25:l 
Nr 01 EL16 stimulator cells 
Figure2. The cytotoxic response against a combination of  AC and 
supernatant plus 5 x IO5 irradiated DBA/2 spleen cells and variable 
NWT. C3H responder cells (2 X IO') were incubated with 0.4 ml EL-4 
group of cultures received 1 : 1 mixtures of these two cell types  (each cell 
numbers of Irradiated BLf6 AC [M) or BLf6 NWT [A-A). A third 
type at  the indicated cell number per culture] [U). Data show the 
cytotoxic activity against  the indicated  target  cells at   the attacker to target 
legend to Figure 1. 
cell ratios 5:l  [top panel) and  25: 1 (bottom panel). For other details, see 
TABLE I 
Cutotoxic responses  against combinations of AC and NWT" 
Stimulator 
Constant 
Cells 
BL f6 
ELI6 
BLf6 
ELI6 
BLf6 
BL/6 
ASW 
A.SW 
A.SW 
ASW 
A.SW 
A.SW 
A.SW 
A S W  
ASW 
A.SW 
A.SW 
Targets 
Varlable Stimulator 
Cells BL/6  BALB/c A S W  ~ _ _ _ ~  
25:l  5:l  25:l  5:l  25:l 5:l 
None 50 26 15 09 n.t.b 
5 X IO3 DBA/P-AC 
1 X lo4 DBAf2-AC 
2 X lo' DBAf2-NWT 50 27 11 06  n.t. 
2 X lO4DBA/2-NWT+ 1 X lo' 47  29 35 17 n.t, 
45 23 24 09 n.t. 
43 22 40 21 n.t. 
DBAI2-AC 
2 X loi DBA/2-NWT f 5 X IO3 
None 
2 X IO4 BL/G-AC 
2 X IO' DBAI2-AC 
1 X 10' BLf6-NWT 
2 X 10'  BLfG-NWT 
1 X lo5 BL/G-NWT + 2 X IO' 
2 X lo' BL/G-NWT + 2 X 10' 
DBA/S-AC 
DBA/2-AC 
DBAJ2-AC 
1 X lO'DBAf2-NWT 
2 X 104DBA/2-NWT 
1 X 10' DBAIP-NWT + 2 X lo4 
2 X lo' DBAf2-NWT + 2 X lo' 
BLf6-AC 
BL/G-AC 
48 
10 
48 
25 
23 
09 
27 
15 
03 
09 
45 
41 
- 
26 
04 
25 
09 
06 
05 
12 
09 
00 
22 
04 
24 
__ 
34 
21 
12 
51 
10 
08 
31 
39 
09 
18 
17 
14 
~ 
13 
05 
12 
31 
05 
06 
18 
18 
12 
08 
06 
06 
- 
n.t. 
44 18 
43 15 
41 15 
39 11 
39 13  
42 1 5  
38 10 
44  11 
39 11 
49  14 
43  17 
with 0.4 ml of an IL 2-containing EL-4 supernatant  and 5 X lo5 irradiated 
a C3H spleen  cells (2 x 10') were incubated as responder  cells  together 
spleen  cells of the  constant  stimulator type plus  the indicated numbers 
were irradiated with a dose of 1500 rad from the Gammaceli 1000 D. 
of variable stimulator cells in 4.5-ml  macrocultures. All stimulator Cells 
Variable stimulator cells were either NWT or AC. Data show percent 
specific "Cr release by the indicated target cells at  attacker to  target cell 
ratios of 25: 1 and 5:  1. 
Not tested. 
tory activity of the AC preparation  was not reduced by 
treatment with anti-Thy-1 serum plus C, whereas the 
stimulatory activity of Cspl was markedly reduced by this 
treatment (Table 111). 
Induction of IL 2 responsiveness  and  cytotoxic  acttv- 
ity in cultures with a single  set of I region-compatible 
stimulator cells. The experiments with two unrelated 
sets of stimulator cells excluded the possibility that  the 
AC or Con A-activated stimulator cells were required for 
the activation of an antigenically  unlinked  helper  effect, 
i.e., for IL 2 production. But these  experiments did not 
allow us to distinguish whether the AC and CNWT or 
Cspl were required for a maturation signal or for the 
induction of IL 2  responsiveness,  which is believed to be 
the  first  event  during  the induction of the cytotoxic re- 
sponse (44, 45). We therefore  tested  the  capacity of dif- 
ferent spleen cell preparations to induce IL 2-dependent 
DNA synthesis  and CTL activity in 0.2-ml  microcultures 
with I region-compatible responder cell populations. Be- 
cause of the disparity in the H-2 D region between re- 
sponder and stimulator cells and  the  absence of third 
party stimulator cells, we expected that  this antigenic 
stimulus would address mainly the CTL precursor cells 
rather  than  the I region-reactive helper cells. The  result 
(Table IV) showed that 3 X lo3 AC and Cspl or CNWT 
induced markedly stronger IL 2-dependent DNA synthe- 
sis, and in addition,  often  stronger cytotoxic activity than 
3 X lo4 NWT stimulator cells. Moreover, the cytotoxic 
and proliferative response  against NWT was not further 
enhanced by adding three times more IL 2 (data not 
shown);  small  doses of AC and Cspl or CNWT stimulator 
cells induced cytotoxic and proliferative responses in the 
presence but not in  the  absence of external IL 2 (Table 
IV). This  result indicated that  the relatively strong  stim- 
ulatory potential of these cells at relatively small  num- 
bers  was  again not explained by stimulation of internal 
IL 2 production but  rather by a more effective induction 
of IL 2  responsiveness. 
The stimulatory potential of dtfferent spleen cell 
preparations In vivo. Studies of primary cytotoxic re- 
sponses  against allogeneic cells in vivo revealed essen- 
tially the  same differences between the stimulatory  activ- 
ities of the various  types of spleen cell preparations (Table 
V). The mice were immunized with  combinations of two 
unrelated allogeneic spleen cell preparations, which were 
injected into the four footpads. The simultaneous re- 
sponse  against  the  constant  set of stimulator  cells  was 
used again as an  indicator for antigenically  linked  helper 
effects.  The mice were also  treated  with cyclophospha- 
mide 2  days before immunization  in most of our experi- 
ments to abrogate the effects of a cyclophosphamide- 
sensitive  suppressor cell system  (46-48). The  strongest 
stimulatory activity was again  expressed by the AC prep- 
aration  and  the CNWT preparation,  whereas  Spl  or NWT 
stimulated  little  or no cytotoxic activity (Table V). Mice 
that have not been treated  with cyclophosphamide gen- 
erated  usually only weak cytotoxic activity,  but he CNWT 
preparation  stimulated clearly stronger cytotoxic re- 
sponses than NWT cells or unfractionated  spleen cells 
(Table V, Expt. 11). (C57BL/6 mice were used in this  case 
because this strain was generally found to produce 
stronger responses than C3H mice without cyclophos- 
phamide.) 
The CNWT preparation mediated in these in vivo ex- 
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cells  before or  after  stimulation with Con 
Ffgure 3. Titration of  NWT stimulator 
A. C3H responder cells (2 X lo7) were 
incubated with 0.4 ml EL-4 supernatant 
plus 5 x los irradiated A S W  spleen cells 
and a variable number of C57BL/6 stim- 
ulator  cells (left  panel) or DBA/2 stimu- 
lator  cells (right  panel). The variable stim- 
ulator cells  were NWT. which  were either 
freshly prepared (A-A) or cultured 
overnight at  a density of 2 x lo7 cells in 
4.5 ml medium containing 0.01 mg Con A (w or 45 ng PMA (0) or  neither Con 
A nor PMA (0). For other  details,  see leg- 
end  to Figure 1. 
40 
20 
s 
E 
LiJ  
- 9 0  
L 
0 
V ._ 
0, 
Q 
60 
40 
2c 
c 
I variable  stimulator:CBTBLIG 
I/. 
variable  stirnulator:DBA12 
-yo 
variable stlmulator'BL/6 
6 )  25: l  
number of variable  stimulator cells 
variable stimulator.DBA/2 
o 2 X 103 2 X 104 2 X 105 o 2 X 103 2 X 104 2 x 105 
Nr. of variable  stimulator cells 
0-0 fresh NWT 
v-v NWT . ConA 24 hrs A-A NWT 4 ConA 30 mln 
Ffgure4. A brief incubation of NWT with Con A is not sufficient to enhance  their stimulatory potential. C3H responder cells (2 x lo7) were 
incubated  with 0.4 ml EL-4 supernatant  plus 5 X 10' irradiated DBA/2 spleen cells (left  panel) or C57BL/6 spleen  cells (rfght  panel) and a variable 
number of  BL/6 stimulator cells (left  panel) or DBA/2 stimulator cells (rfght  panel), respectively. The variable stimulator cells  were NWT that were 
either  freshly prepared (0-0) or were  cultured at  a density of 1.5 X lo7 cells in 4.5 ml with 0.01 mg  Con A for 30 min (A-A) or 24 hr (V-V). 
For other  details,  see legend to Figure 1. 
periments an augmentation of the  simultaneous re- Tumor cells as stimulator cells for cytotoxic re- 
sponse against the second set of stimulator cells. The sponses in vitro and in vivo. Tumor cell lines provide, in 
CNWT preparations were nevertheless not able  to recon- contrast to spleen cell fractions, relatively homogeneous 
stitute  the weak stimulatory potential of an unrelated stimulator cell populations.  The  comparison of the  stim- 
allogeneic NWT preparation  (Table V, groups 14 to 18). ulatory activity of several  tumor  lines confirmed the basic 
The  activating  signal (possibly a helper  factor) from the conclusion from our previous experiments that different 
CNWT population  was  again  preferentially delivered to cell types differ markedly in their capacity to activate 
those CTL precursor cells that expressed  antigen recep- CTL precursor cells even in the presence of IL 2-contain- 
tors for antigenic  determinants  on  these CNWT. ing EL-4 supernatant  and/or a second set of stimulator 
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TABLE I1 
Cytotoxlc responses  against combinations of small numbers of AC 
and Cspl or CNWTD 
Targets 
BALB/c  A.SW 
DBAj2 Stlmulator Cells 
Group AC Cspl CNWT 25:l 5:l 25:l 5:l 
1 0 0 0 11.5 5.2 29.5  11.8 
2 1 x 10' 0 0 32.7 16.4 30.4 14.4 
4 
0 22.6 9.5 34.7 18.3 
0 1 X lo' 0 23.2  1 .6  28.8  16.  
5 
6 0 1 X IO3 0 17.2 7.3 35.8 14.0 
0 5 X lo3 0 16.5 8.6 31.5 13.4 
7 
8 
1 X 10' 1 X 10' 0 36.9 15.3  34.8 15.6 
1 X 10' 5 X lo3 0 33.2  12.0 38.0 17.7 
3 5 x  103 o 
9 1 X 10' 1 X lo3 0 32.6 14.8 32.8 15.7 
10 5 X 103 5 X lo3 o 28.2 8.8 32.7 13.9 
11 5 X lo3 1 X lo3 0 23.7 9.8 38.0 19.2 
o 5 x  103 21.8 11.2 38.7 19.3 
1 X 10' o 5 X 103 33.3 12.2 33.3 13.6 
12 0 
1 3  0 
0 1 X lo4 18.9 8.1 28.7 16.6 
15 
14 1 X lo4 0 1 X 10' 37.2  16.2 32.3 14.1 
16 5 X lo3 0 5 X lo3 30.9  10.7 39.1 19.5 
lo5 mitomycin C-treated A.SW cells and 0.4 ml EL-4 supernatant plus 
a C3H spleen cells (2 x lo') were incubated in 4.5-ml cultures with 5 x 
the indicated numbers of mitomycin C-treated DBA/2 stimulator cells. 
The DBA/2 stimulator cells were either AC, Cspl. or CNWT. Data show 
the percent specific "Cr release by the indicated target cells at  attacker 
to target cell ratios of 25: 1 and 5: 1. 
TABLE 111 
Effect of anti-Thy-l  antibody plus C on the  stimulatory  potential of 
AC and CSO~" 
Variable  Stimulator 
Populatlon 
Expt. 1 
2 x 10' BL/6-Csplfa-Thy-1 
None 
2 x lo4 BL/G-Cspl/a-Thy- 1 
plus c 
only, no C 
2 X lo4 BL/6-Cspl/no a-Thy- 1, 
C only 
no C 
2 x 10'  BL/G-Cspl/no a-Thy- 1. 
Expt. 11 
None 
3 x 10' BL/6-AC/a-Thy-1 
1 x lo' BL/6-AC/a-Thy-1 
plus c 
3 x 10' BL/6-AC/a-Thy-1 
1 x lo4 BL/6-AC/a-Thy-1 only. 
3 x lo' BL/G-AC/no a-Thy-l , 
1 x 10'  BL/G-AC/no a-Thy-1 ~ 
plus c 
only. no C 
no C 
C only 
C only 
Targets 
C57BL/6  A.SW 
25:l 5:l 25:l 5:l 
12.6 3.9 19.5 6.2 
5.4 0.7 19.6 7.9 
29.0 14.1 23.5 6.0 
26.5 7.8 18.8 4.6 
27.3 11.4 24.7 7.4 
C57BL/6 BALB/c 
56.6 34.6 64.7 36.6 
14.3  5.2 61.3 30.0 
38.6 21.2 64.7 37.3 
53.2 27.9 64.7 37.3 
36.0 15.3 65.8 37.0 
39.5 14.9 62.9 36.3 
20.9 8.2 59.6 34.5 
supernatant  and 5 x lo5 irradiated A S W  (Expt. 1) or DBA/2 (Expt. 11) 
OC3H responder cells (2 X lo7) were incubated with 0.4 ml EL-4 
spleen cells plus the indicated numbers of Con A-activated BL/6 spleen 
cells or BL/6 "adherent cells". The BL/6 stimulator cells had been treated 
in two cycles with anti-Thy-1 antibody (30 min. 4'C) and C (45 min. 
only. The antl-Thy-1 antibody was a monoclonal antibody kindly provided 
37'C).  In the control groups. the cells were incubated in culture medium 
by Dr. G. Hammerling. Low toxicity M rabbit complement was obtained 
from Cedarlane. Hornby, Ontario, The efficiency of this treatment  was 
routinely tested on thymocytes and nude spleen cells. 
cells. 
Irradiated  tumor cells of the line  ESb mediated a gen- 
eral  antigen-nonspecific  suppression of the cytotoxic re- 
sponses  against  both H-2 haplotypes  tested if added in 
doses of 1 O4 cells  to the  cultures with C3H responder cells 
and IL 2-containing EL-4 supernatant  plus a second set 
of allogeneic stimulator cells (Table VI). The variant 
ESbM, in  contrast, did not suppress  but stimulated at the 
TABLE IV 
dependent DNA synthesis and CTL actlulty In I region-compatible 
Capacity of dltferent  spleen cell preparatfons to Induce IL 2- 
responder cell populat6ns' - 
% "Cr Release 'H Incorporation (corn X io-3) 
Stimulator  Cells 
. .  
-EL-4 +EL-4 -EL-4 +EL-4 
sup.  sup.  sup. sup. 
Expt. I: responder:CSH.OH (H-2KdldP): stimulator: DBA/2 and BALB/c 
None 
(H-zd]; target:BALB/c. 
4.1  3.9 1.4  15.2 
4.9 21.2 2.5 46.5 1 x 1 0 ~ .  
1 x 104 
1 x 1 0 ~ '  
1.4 16.2 1.5 25.0 
3 x 102 
, BALB/c-Cspl 17.4  33.1 23.2 46.8E :$ 16.3  34.4 27.5 63.9 
1 x 1 0 ' '  
4.2 13.8 13.0 35.4 1 x 103 
6.7 26.4 3.1 33.9 
7.2  12.8  1.7 21.7 
Expt. 11: responder:C3H (H-2'); stimulator and target: A.TL  (H-2K*IkDd) 
None 
1 x 105 
-2.5 -3.6 3.5 13.9 
-1.0 18.7 0.7 47.9 
3 x lo4 A.TL-NWT -1.2 18.4 0.9 34.2 
1 x 104 
3 x  io3 ' 
-2.2 11.8 1.7 26.5 
-0.2 14.2 10.9 68.5 
1 x lo3 .A.TL-AC 
3 x 102 
-1.8 11.9 
-2.4 0.9 
1.6 24.6 
3 x  103 ' 
1.7  15.6 
-2.1 31.9 16.2 114.4 
1 x 103 A.TL-CNWT -1.7 21.6 6.4  63.0 
3 x 102 -2.0 5.0 2.5 15.0 
3 X 10' . DBA/P-NWT 4.4 29.7 6.8 32.2 
3 X lo3 * DBAIO-AC 
8.8 27.4 54.7 140.9 
19.3 29.4 35.6 69.9 
types of irradiated (1500  rad)  stimulator cells in 0.2-ml microcultures 
NWT (5 x lo4) were incubated as responder cells with the indicated 
with or without 0.01 ml  EL-4 supernatant. One set of cultures received 1 
&I ('Hithymidine 3 days later and was harvested with a Skatron cell 
harvester after  another 8 hr. A parallel set of cultures  was incubated for 
Similar results were obtained with 0.03 ml  EL-4 supernatant per culture. 
5 days and tested for cytotoxic activity against the indicated target cells. 
concentration of lo4 cells per culture a substantial cyto- 
toxic response  against the homologous  H-2d target:  tumor 
cells of the lines  P815, Meth A, and  Eb did not suppress 
or  stimulate at  these cell concentrations (Table VI). Sim- 
ilar  results were obtained  with EL-4 and RBL/5 tumor 
cells: a t  lo4 cells per culture they did not stimulate a 
cytotoxic response  against the homologous  H-2b targets 
and did not affect the simultaneous response against 
A.SW stimulator cells in the same culture [data not 
shown).  The  ESb  mutant  lines ESbW and ESbD, on the 
other hand, had a stimulatory activity similar to the 
ESbM line (Table VI, Expt. 11). Cells of the tumor  lines 
P815  and Meth A were also  tested in mixtures  with H-2 
identical DBA/2 adherent cells as stimulator cells to ex- 
clude the possibility of an antigen-specific  suppression 
that would not  have  been detected in  the experiment of 
Table VI. Again, we observed some antigen-nonspecific 
suppression at high tumor cell concentration ( lo5 cells 
per culture),  but no  suppression at lower tumor cell con- 
centrations  (data not  shown). 
Similar  differences between the stimulatory  activities 
of the  tumor cell lines were observed in primary cytotoxic 
responses in uluo (Table VII). The  tumor cells were in- 
jected into the footpads of cyclophosphamide-treated 
mice together with a constant number of allogeneic 
spleen cells of another H-2 haplotype. Again, only the 
irradiated (1 500 rad) ESbM cells stimulated  strong cyto- 
toxic responses,  whereas  several  other  tumor  lines  acti- 
vated only minute  responses  against  their own H-2 anti- 
gens  (Table VII). Most tumor cells including the irradiated 
(1 500 rad)  ESb cells at higher  doses mediated suppres- 
sion of the response  against the second set of stimulator 
cells if tested  in C3H mice. Immunization with  combina- 
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TABLE V 
2755 
Stfmulation of cytotoxfc responses in vivo by dlfferent  types of spleen cell preparations' 
X Speclflc "Cr Release  wlth  Targets 
Expt. I: 
1 
2 
3 
4 
5 
6 
7 
8 
10 
9 
11 
12 
13  
14 
25 
16 
17 
18 
Expt. 11: 
20 
19 
21 
23 
22 
24 
25 
27 
26 
28 
Group  Injected  Cell  Preparatlans 
BL/6 (H-27 BALB/c (H-2d) 
Cyclophosphamide-treated C3H mice 80: 1  27:  1 9: 1 80: 1 27: 1 
3 x lo7 BL/G-spl + 3 x lo7 BALB/c-spl 14 9 5 9 2 
6 x 10' 3 x lo7 2  n.t.b n.t.  n.t.  n.t. 
15 6 
9 3 
1.2 x 10' 3 X 10' 4 -1  -1 
3 X lo7 BL/G-NWT + 3 X lo7 BALBfc-spl 5 0 0 
29 
30 
6 X 10' 
3 X lo7 BL/6-CNWT 
6 X 10" - .. 
1.2 x 10' 
2.4 X 105 
6 X 10'  BL/6-AC 
2.4 X lo5 
1.2 x 10' 
- 
6 X 10'  BLfG-spl 
6 X 10" BL/G-NWT 
6 X 10" BL/G-AC 
6 X 10'  BL/G-CNWT 
- 
+ 3 x 1 O7 BALB/c-spl 
3 X lo7 
3 x lo7 
3 x 10' 
3 X 10' 
3 X lo7 
3 x lo7 
+ 3 X 107 BALB~C-SPI 
+ 6 X 10'  BALB/C-CNWT 
3 X 1 O7 BALB/c-spl 
6 X 10' 
6 X 10' 
6 X 10' 
6 X 10' 
8 1 
37  26 
21 9 
10 6 
2 0 
21  10 
5 
3 
0 
1 
1 
9 
-1 
-3 
0 -2 
24 7 
26 9 
3 -1 
C3H (H-2') 
13 
2 
5 
3 
2 
5 
2 
2 
0 
-2 
-3 
1 
2 
0 
BL/6 mice without  cyclophosphamide 
3 X lo' C3H-spl + 3 X lo7 Balb/c-spl 
6 X 10' 3 x lo7 
3 X lo7 C3H-NWT 3 X lo7 
6 X 10' 3 x lo7 
3 X lo7 C3H-CNWT 3 X lo7 
6 X 10' 3 x 10' 
1.2 x 10' 3 X lo7 
1.2 x 10' 3 X lo7 
1.2 t 10' 3 x lo7 
1.2 x 10' 3 X 107 
6 X 10'  C3H-AC 3 X 107 
100: 1 
4 
33: 1 
2 
2  1 
2 
3 
1 
1 
0 0 
1 0 
11 5 
4  2 
2 
6 
1 
3 
1 0 
11:l 
2 
2 
1 
0 
1 
0 
2 
1 
1 
1 
1 
16 4 
16 7 
16 6 
24 
16 
11 
7 
10 3 
9 3 
18  12 
14 6 
9  2 
10 2 
13 4 
13 6 
5 0 
BALB/c (H-2d) 
1OO:l 
0 
3 
4 
7 
3 
3 
4 
5 
4 
4 
1 
33: 1 
1 
1 
3 
3 
1 
2 
1 
2 
1 
2 
0 
_ _ ~ ~  ~ ~~ 
"Ten-week-old male C3H (H-2') mice (Expt. I) and 8-wk-old male C57BL/6 mice (Expt. 11) were immunized with the indicated cell preparations: the 
cytotoxic activity of the pooled axillary and inguinal  lymph node cells (two mice per group] was tested 5 days  later with a 4-hr "Cr-release assay with 
Con A-activated lymphoblasts of the indicated strains used as target cells. Data show  the % specific "Cr release. The C3H mice (Expt. I) were treated 
and  distributed  in equal aliquots into the four footpads. The cells had been  irradiated  with 1500 rad. 
with 3 mg of cyclophosphamide i.p. 2 days before immunizatlon. The indicated cell preparations  and cell numbers were administered in  0.2 ml BSS 
Not tested. 
Targets 
Tumor  Cells  (Reported  Orlgln) H-2d H-2b 
Expt. I 
None 
P815 mastocytoma (DBA/2) 
Meth A fibrosarcoma (BALB/c) 
Eb T  lymphoma (DBA/2) 
ESb T  lymphoma (DBA/2) 
ESbM T  lymphoma (DBA/2) 
Expt. I1 
None 
Eb T  lymphoma (DBAIP) 
ESbM T lymphoma (DBA/2) 
ESbW T  lymphoma (DBA/Z) 
ESbD T lvmohoma fDBA/2I 
25:l 5:l 25:l  5:l 
0 0  
6 2  
4 0  
3 -1 
39 26 
1 2  
5 3  
9 4  
19 8 
14 4 
17 4 
24 8 
30 19 
34 16 
38 17 
20 8 
0 -5 
45 27 
48 39 
48 25 
47 28 
36 20 
"C3H spleen  cells (2 x lo') were incubated as responder  cells in 4.5- 
ml cultures with 0.4 ml EL-4 supernatants  and 5 x 10' irradiated (1500 
cells  (Expt. I) or 3 x lo4 mitomycin C-treated tumor cells (Expt. 11) of the 
rad) C57BL/6 spleen  cells (H-zb) plus 1 X 1 O4 irradiated (1 500 rad) tumor 
indicated lines (all H-2d). Data  show the % speclfic "Cr release. 
tions of tumor cells and Con A-activated spleen cells of 
an  unrelated haplotype gave similar results (data not 
shown). 
The  expression of major histocompatibility class I 
and  class I1 antigen  on  the  various  types of stimulator 
cells. Two independent  strategies were used to  ensure 
that  the various  types of stimulator cells expressed the 
expected H-2 antigens,  namely i) the  analysis of antigen 
density  with monoclonal antibodies  in  combination  with 
a fluorescence-activated cell sorter (FACS); and ii) the 
sensitivity  against  a  panel of CTL with known specifici- 
ties. 
The FACS analysis of several  pairs of NWT and CNWT 
preparations from different strains of mice  (Fig. 5, Table 
VIII) revealed that the NWT did contain substantial 
amounts of class I antigens (Ld and Dd or Kb and Db), 
although the antigen  density  was slightly lower than on 
the CNWT preparations. Moreover, the CNWT prepara- 
tions in contrast to the NWT preparation  contained de- 
tectable amounts of class I1 antigens (I-Ed or I-Ab). The 
AC preparations expressed similar densities of class I 
antigens  and relatively high densities of class I1 antigens 
(data not  shown). 
The FACS analysis of several  lines of tumor cells re- 
vealed that all  tumor cells expressed class I alloantigens 
(Fig. 6, Table IX). The T lymphoma lines ESbM, ESbD, 
and RBL/5 also  expressed  detectable amounts of class I1 
alloantigens. The strongly stimulatory line ESbW ex- 
pressed no detectable amounts of class I1 antigens  and 
normal levels of class I antigens,  similar to the  antigen 
levels of the weakly stimulatoIy  lines P815, Meth A, and 
Eb. Additional experiments confirmed that the tumor 
lines  with weak stimulatory activity (Le,, Meth A, P815, 
RBL/S, Eb, and ESb) were effectively lysed by allospecific 
CTL  of the correct specificity H-2d and H-2b, respectively, 
if labeled with 51Cr and used as target  (data not shown). 
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TABLE VI1 
Stfmulatton ofcytotoxic responses tn uLu0 by tumor cells tn rnlxture 
wlth allogenetc spleen cells" 
lnjected 
Croup Tumor 
InJected  Targets 
Allcgenelc 
Cells  Cells 1OO:l 33:l 11:l 1OO:l 33:l  11:l 
RBL/5 (H-2') BALB/c ( H - 2 d J  
3 x 107 
3 x 106 
3 x lo7 
3 x 10' 
3 x 105 3 x 107 
P815 ( H - 2 d )  C57BL/6 iH-2b) 
5 X 107 3 X 107 
5 x 10s 3 x lo7 
5 x 1 0 5  3 x 107 
Meth A (H-2'1 
3 X 107 
3 x 105 
3 x 106 
Eb (H-Zd)  
5 x 106 
5 x 107 
5 x 105 
ESb lH-Zd)  
1 x 107 
1 x 1 0 s  
ESbM [H-2dJ 
1 x 105 
3 x 107 
3 x 10s 
P815 f H - 2 d )  
3 x 105 
3 x 107 
3 x 105 
3 x 109 
ESbM IH-2d) 
3 x 107 
3 x 106 
3 x 105 
C57BL/6 
3 x 107 
3 x 10' 
3 x lo7 
C57BL/6 
3 x 10' 
3 x 10' 
C57BL/6 
3 x 107 
3 x lo7 
3 x lo7 
3 x 107 
3 x lo7 
3 x 10' 
3 x 107 
3 x lo7 
3 x lo7 
3 x lo7 
3 x lo7 
3 x 107 
3 x 10' 
C57BL/6 
CBA/J (H-2') 
CBA/J 
BL 16 
-6 -6 -5 
-3 -4 -4 
-6 -6 -5 
7 6 1  
BALB/c 
4  2 -4 
1 5 -1 
9 0 1  
BALB/c 
8 5 -2 
2 4 -5 
8 5 2  
BALB/c 
3 3 1  
3 2 2  
6 6 0  
3 2 -2 
2 1 0  
33 24 9 
BALB/c 
14  13 7 
0 1 1  
BALB/c 
5 2 0  
-1  0 0 
-6 -4 -3 
36 24 15 
BALB/c 
12  12 5 
11 7 0 
BALB/c 
BALB/c 
14 6 0 
14 10 3 
22 12 3 
BL/6 
1 1 -1  
11  1 -2 
30 19 6 
BL/6 
24 20 11 
19 14 9 
20 13 9 
BL/6 
-1 1 -4 
30 21 8 
24 15 3 
11 "2 2 
34 26 12 
17 20 8 
9 13 4 
BL/6 
22  20  14 
L 929 lH-2*)  
25 19 10 
22 18 5 
25  17 8 
19 11 5 
L 129 (H-2') 
32 21 7 
30 17 11 
31 21 10 
"Eight- to 12-wk-old male C3H (H-2*] mice (groups 1-6) or C57BL/6 
(H-Zb) mice (groups 7 and 8) received injections of 3 mg of cyclophospha- 
mide i.p. and 2  days  later  a mixture of the indicated numbers of 1500 
into the four footpads. The cytotoxic activity of the pooled axillary and 
rad-irradiated tumor cells and allogeneic spleen cells equally distributed 
assay by using either Con A-activated lymphoblasts of the indicated 
inguinal lymph node cells was tested 5 days  later with a 4-hr "Cr-release 
"Cr release f SE. Some tumors (Le.. P815. Meth A, Eb. RBL/S. and the 
strains or L 929 tumor cells (H-2*) as  target cells. Data show the '70 specific 
treated with cyclophosphamide and were found to stimulate no detectable 
El-4 standard line were also injected Into C3H mice that had not been 
to  stimulate substantial cytotoxicity in C3H mice without cyclophospha- 
cytotoxicity. The ESbM tumor cells. on the other hand, were also found 
mide [data not shown). 
DISCUSSION 
Our  experiments confirmed and extended our previous 
observation (49) that  the activation of  CTL precursor cells 
requires more than interaction  with  the physical struc- 
ture of the  antigen  plus an  antigenically  unlinked deliv- 
ery of IL 2 and other helper factors. The experiments 
demonstrated that different spleen cell fractions and 
tumor cell lines  differ  markedly (on a per cell basis]  in 
their  capacity  to  stimulate cytotoxic responses in vitro in 
the presence of an 1L 2-containing cell supernatant  and 
a second set of stimulator cells. (This implied that  the 
various  types of stimulator cells differed in their  capacity 
to activate the CTL precursor cell or an  unknown type of 
helper cell that  interacts with the CTL precursor  through 
an  antigenicdy linked helper  effect.)  Strong  stimula- 
tory activity was expressed by Con A-activated T cell 
preparations (CNWT),  by AC preparations, and by some 
variant lines of the ESb T lymphoma.  These cell types 
stimulated substantial cytotoxic activity in doses of lo4 
cells per  culture  or  less. Cells of the regular ESb T lym- 
phoma  line were found to mediate  nonspecific  suppres- 
sion.  Several  other  tumor cell lines and unfractfonated 
spleen cells or the NWT fraction (mostly resting  small  T 
lymphocytes) stimulated substantial cytotoxic responses 
DBA / 2  - CNWT 
BALBlc-NWT 
YI 
BALB /C - CNWT 
C576l6-NWT 
a-D* [control) 
,u - IAb 
Relative  Fluorescence  Intensity 
histocompatibility antlgens on NWT and CNWT cell preparations. The 
Ftgure 5. FACS analysis of the expression of class I and  class Il major 
descriptions of the monoclonal antibodies and  the proportion of fluores- 
cent cells are shown in Table WII. 
only at higher cell doses. These cell preparations did not 
actively suppress  the cytotoxic response at doses of lo4 
cells per  culture. 
Complementary in vivo experiments confirmed in es- 
sence  the  in vitro observations and underlined  their sig- 
nificance.  The  immunization of mice with  mixtures of 
two unrelated  types of allogeneic cells revealed practi- 
cally the  same  pattern of stimulatory activity: only the 
CNWT, the AC, and some variants of the ESb T lym- 
phoma  stimulated substantial cytotoxic responses if in- 
jected in numbers of 6 X 1 O6 cells per mouse or less. 
Two independent  methods,  i.e.,  fluorescence  staining 
with  a monoclonal antibody  in combination with cyto- 
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TABLE VI11 TABLE IX 
Proportion (%) offluorescent  cells in preparations of NWT and CNWT Proportion (7%) offluorescent  cells in dtfferent tumor cell  preparations 
as defined  by a constant  arbitrary  threshold" a s  defined by a  constant  arbitrary  threshold" 
Strain Antibody NWT CNWT Antlbody Used 
DBA f2 Anti-]-Ed (13-4) 8.9 45.2 
Anti-Dd (T19-191) 61.9  65.4
Anti-Ld (28-14-8) 59.4  63.0 
Anti-Kb (K 10-56) 7.7 9.8 Expt. I 
BALB fc Anti-I-Ed (1  3-4) 5.4 33.6 P815 7.8 85.5 46.8 61.7 8.1 
Anti-@ (T19-191) 90.9 89.3 MethA 3.0  77.3 37.1 33.6  8.2 
Anti-Ld (28-14-8)  90.9  72.5 RBLf5 11.6  24.3 89.1 96.4 
Anti-Kb (K10-56) 3.4 12.9 EL-4b 8.3 6.3 84.7 89.1 
6.1 
Anti-Kb (K10-56) 65.6 79.3 ESbM 32.9 46.7 17.3 37.9 10.5 
Anti-Db (B22-249) 77.6 89.7 ESbW 6.8 91.3 50.1 80.6 9.8 
Anti-Dd (43-2- 12) 5.0 17.4 Expt. I1 
ESbD 54.0 97.4 61.3  94.8 
Eb 
10.9 
1.0 70.6 38.1  6 .3 0.9 
ESbM 60.3 73.0 48.6 65.8 
ESbW 1.3 94.6 49.3  74.4 3.3 
2.4 
anti-I-Ab antibody. These were cells from the IL 2 high producer subline 
*The EL-4 data have been included to show a negative control for the 
of EL-4 kindly provided  by  Dr. J. Farrar. 
fluorographic analysis  and incubation  with alloreactive 
cytotoxic T cells of known specificity were used to ensure 
that all cell types  expressed the expected H-2d or H-2b 
Tumor 
~i~~ Anti-I-Ed Antl-Kd Anti-Dd Anti-Ld Anti-I-Ab Anti-Kb Antl-Db 
(13-4)  (31-3-4)  (34-2-12)  (28-14-8)  (25-5-16)  (K10-56) (822-249) 
C57BL/6  Anti-I-Ab ( 1  7-227) 7.9 36.8 ESb 4.3 95.4 43.2 82.9 
"Quantitative  data for the  analysis in Figure  5. 
Exp. I Quantitative data for the analysis In Figure 6. 
a -Dd a - D d  
a-Kd 
a- Kd class I alloantigens.  The NWT and CNWT preparations 
/ differed slightly with respect to the  density of class I 
antigens  and also in the expression of class I1 alloanti- 
gens;  but  the relatively strong  stimulatory  activity of the 
ESbW T lymphoma line in comparison  with  other  tumor 
- a - D d  lines  indicat d that  an exceptionally high density of class 
I antigen or the expression of class I1 antigen  was not 
, a - IAb necessary  for th   expr ion of strong  stimulatory  activ-
ity. Our experiments suggested that  the effective stimu- 
lator cells for the CTL precursors provide an additional 
activating signal, possibly an antigen-specific helper 
factor or a nonspecific short-range  factor, in addition to 
the antigenic  stimulus by the relevant  class I alloantigen. 
Complementary experiments with a single set of stimu- 
lator cells and I region-compatible responder cells (Table 
IV) indicated that  this additional  activating  signal is re- 
quired for  the induction of IL 2 responsiveness, which is 
believed to be the  first  step in the activation of cytotoxic 
responses (44, 45). 
Of particular importance is our observation that  the 
EXp. potent stimulator cells had relatively little or no effect on 
the magnitude of the  bystander  response,  and conversely 
that  an ongoing bystander  response  was not sufficient to 
support the response  against the weak stimulator cells. 
The  additional  activating  signal  was obviously delivered 
only to those CTL precursor cells that carried antigen 
receptors that could bind to antigens on the signal-deliv- 
ering cell. This  point is expected to  have  practical impli- 
cations for attempts to generate cytotoxic responses 
against  tumor cells. It is conceivable that  the stimulator 
ESb-W cells produce (or stimulate the production of) one of the 
helper factors  that  are required in addition to IL 2 for the 
activation of CTL (21-28). Reports on these additional 
factors (21-28). however, have not dealt with  antigen- 
specific aspects of these helper  effects:  i.e.,  they did not 
indicate  whether the  factors  are delivered by a cognate 
interaction that involves the  antigen receptor of the CTL 
Relat. Fluorescence signed to demonstrate the antigen-specific  aspect of the 
ESb - D 
_- 7 precursor cell. The  experim nts in this report were de- 
histocompatibility antigens on various lines of tumor cells. The descrlp- 
Figure 6. FACS analysis of the expression Of class I and class I1 major additional  activating  signal. It has been reported that  the 
tlon of the monoclonal antibodies and  the proportion of fluorescent cells Of requires 
are shown in Table IX. metabolically active  stimulator cells, but may be achieved 
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also with UV-treated stimulator cells if the system is 
flooded with an  IL 1-containing  lymphokine  preparation 
(50). This result indicated that  the T cells receive the 
activating  factor IL 1 directly from the stimulator cells, 
i.e., by a cognate interaction with the IL 1-producing 
macrophages. In analogy to this situation, we propose 
that  at least  one  helper  factor for the activation of the K 
and D region-restricted CTL precursor cells is also  usually 
provided  by the stimulator cells, i.e., the factor may be 
delivered in  sufficient  concentrations only if the antigen 
receptors of the CTL precursor cells can bind to  antigenic 
determinants on the factor-producing cells. The  hypoth- 
esis  predicts i) that Stimulatory activity is only (or opti- 
mally) expressed by certain cell types, and ii) that it is 
dependent on the metabolic activity of the stimulator 
cells. Both predictions were indeed confirmed by the 
experiments  in  this  and a preceding (49) report. 
Unexpected was  our  observation that a relatively high 
stimulatory  potential was provided by two very different 
types of cell preparations,  namely by  CNWT and by AC. 
The  former cell preparation  contained  mainly  activated 
T cell blasts  and  the  latter consisted, according to reports 
from other  investigators (6), essentially of dendritic cells 
plus a small  percentage of macrophages. The  stimulatory 
activity of the AC preparation  was  not  affected by treat- 
ment  with  anti-Thy- 1 serum plus C, whereas  the activity 
of Con A-activated spleen cells was strongly reduced by 
this  treatment. A synergistic  effect between CNWT and 
AC was not observed. Taken  together, these  results sug- 
gest that  the  same  activating signal (possibly a  factor) 
may be produced equally well  by T cell blasts and by AC, 
or stimulation by the two cell preparations may involve 
different  mechanisms. 
Our  observation that splenic  responder cells in  contrast 
to thymic responder cells (data not shown] generated 
weak but detectable cytotoxic activity also  against the 
“weak stimulator” cells suggested the possibility that a 
small  subset of splenic CTL precursor cells, i.e., possibly 
the Lyt-l-2+  subset,  does  not  require  the  additional  acti- 
vating  signal  for  stimulation. The clearly demonstrable 
stimulation of splenic  responder cells by metabolically 
inactive  stimulator cells has previously led to  the widely 
accepted concept of  CTL activation (45, 51) that the 
interaction of antigenic  determinants with the  antigen 
receptor of the CTL precursor cell provides by itself a 
first signal that triggers this cell to  express  receptors for 
the growth factor IL 2. The CTL precursor cell was 
thought  to  require  for its activation  neither a special type 
of stimulator cell (9) nor a metabolically active  stimulator 
cell (5, 10,  11,  44,  52).  and it was found  to be activated 
even by noncellular  antigen  (14-  19). provided an IL 2- 
containing cell supernatant (5, 9, 12, 14-19, 52) or a 
second set of stimulator cells of an  unrelated H-2 haplo- 
type (10,  11)  was added to the cultures. We believe that 
these previous observations on  the  antigen  requirements 
for cytotoxic responses were misleading and may apply 
only to a  small  subset of  CTL precursor cells. Considering 
the relatively large numbers of stimulator cells, stimula- 
tion  was indeed inefficient in the previous studies. Our 
experiments, in contrast, were performed with relatively 
small  numbers of stimulator cells. Only the  titration of 
the  stimulator cells revealed that different cell types dif- 
fer markedly in their  capacity  to  stimulate the CTL pre- 
cursor or an antigenically linked helper effect. Graded 
doses of stimulator cells have been used to  demonstrate 
that cultures  without  T cell growth factor  require more 
stimulator cells than cultures  with  this  factor (53); how- 
ever graded doses have not been used to compare the 
stimulatory  capacity of dflerent  stimulator cell prepa- 
rations‘in  the  presence of T cell growthfactor (53). 
It has been suggested (1 2) that  the failure of tumor cells 
to  stimulate an antigenically  unlinked  helper  effect (i.e., 
IL 2 production) may be the main  reason for their  weak 
stimulatory  potential.  This  limitation would have been 
overcome by activating  helper cells of unrelated specific- 
ities. Our experiments showed, however, that  the acti- 
vation of CTL precursor cells requires an antigenically 
linked activating  signal in addition to the physical struc- 
ture of the  antigen on the  stimulator cell. If the weak 
stimulatory  potential is a property of most tumor cells, it 
is not surprising  that CTL play a  minor role in vivo in 
tumor  allograft rejection and syngeneic tumor rejection 
as suggested recently by several authors  (54, 55). 
Macrophage-like stimulator cells are known to process 
and  present  antigen, including  tumor cell antigen  (56).  in 
immunogenic form to T cells. But antigen processing by 
T cells or  T cell blasts has not  been observed. The effec- 
tive activation of  CTL precursor cells by antigen-bearing 
T cell blasts thus may normally be confined to viral 
antigens,  because  viruses may be the only pathogens that 
integrate their components into the surface of T cell 
blasts. This  fact may at least  in  part  explain why CTL 
were found  to be activated in  vivo by virus (57)  and by 
allografts (58) but usually  not by tumors. 
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